{"SPADE_UN_15848": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15848", "Peptide Name": "Magainin-2 [G3,18Dap; K4,10,11,14Dap; F5W; A15Dap; E19Dap; M21Nle]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GIXXWLHSAXXFGXXFVXXIXNS", "Sequence Length": 23, "UniProt Entry": ["http://www.uniprot.org/uniprot/P11006"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:PANC-1 (EC50=61.4±1.7 µM(pH=7.4))", "Hemolytic Activity": "Human kidney-derived GM cells:EC50=7.6±2.1 µM(pH=6); EC50=25.6±4.5 µM(pH=7.4)", "Cytotoxicity": "HEK293:EC50=15.7±1.8 µM(pH=7.4)", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C75H88N18O9", "Mass": 276822, "PI": 7.55, "Net Charge": 1, "Hydrophobicity": 0.626, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues", "Pubmed ID": "31161686", "Reference": "Chembiochem. 2019 Aug 16;20(16)2109-2117.", "Author": "Tanishiki N, Yano Y, Matsuzaki K.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31161686"}], "Frequent Amino Acids": "XFG", "Absent Amino Acids": "CDEKMOPQRTUY", "Basic Residues": 1, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 6, "Positive Residues": 1, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_15845", "Similarity": 0.8571428571428571, "Sequence": "GIKWLHSAKKFGKFVKKINS"}, {"SPADE_ID": "SPADE_UN_15846", "Similarity": 0.8571428571428571, "Sequence": "GIKWLHSAKFGKFVKINS"}, {"SPADE_ID": "SPADE_UN_15847", "Similarity": 0.8571428571428571, "Sequence": "GIKWLHSAFGKFVINS"}]}}}